NPM1 and acute myeloid leukemia: For instance, the spontaneous achievement of MRD negativity in post-chemotherapy MRD+ AML patients bearing the NPM1 mutation [70] potentially mirrors the gradual eradication of the residual leukemic burden through the restoration of an effective antileukemic immune response after chemotherapy.